A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B
Clinical trial NCT03439488 · COMPLETED
Trial details
- NCT number
- NCT03439488
- Sponsor
- Alios Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2019-10-10
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.